
Khalid Shah
@khalidshahs
Vice Chairman of Research @BrighamWomens, Professor @harvardmedicalschool, Founder Amasa Therapeutics, Director, Center for Cell Therapies for Cancer
ID: 1447478761
http://csti.bwh.harvard.edu 21-05-2013 23:02:14
395 Tweet
1,1K Takipçi
966 Takip Edilen

#JoinUs next Wed Jan 18 at 12pm ET for Mass General Brigham Innovation Grand Rounds. Dr. Khalid Shah Khalid Shah Brigham and Women's Hospital will present "The Concept of Innovation and Orchestration: Translating Therapies from Bench to Bedside" Register online: partners.zoom.us/webinar/regist…



Agitation, Innovation, and Orchestration. Fantastic lessons from Brigham and Women’s Research Khalid Shah live now in Mass General Brigham Innovation Grand Rounds! Chris Coburn Mass General Brigham MESH Incubator™ at Mass General Brigham


Cell therapy engineered to eliminate established tumors, train immune system to prevent cancer recurrence Khalid Shah Kok Siong Chen hms.harvard.edu/news/vaccine-s… HSCI Brigham and Women's Neurosurgery Harvard Medical School NIH Science Translational Medicine



What if vaccine could revolutionise medicine all over again? Khalid Shah team is working on a cell-based vaccine to train the immune system to recognize and eliminate certain types of cancer cells. This could prevent relapse and metastasis Brigham and Women's Hospital link.sciencerehashed.com/episode49


Watch this clever heron throw shade—literally nationalgeographic.com/animals/articl… via National Geographic







Our recent News & Views article in Nature Materials highlights two recently published significant contributions on how to mitigate the toxicity associated with CAR T therapy. Excellent work by Liang Lab and Mike Mitchell. Great summary Chuang Liu doi.org/10.1038/s41563…

Headache or sore all over after bad night’s sleep? news.harvard.edu/gazette/story/… via Harvard University

Call for Abstract still OPEN || 3rd SACT - An Asia Pacific Cell Therapy Conference || 1-3 Feb 2024 || sactevent.in/abstract-submi… Meet the Faculty -Translational Track Khalid Shah Harvard Medical School


Our team has developed humanized models of highly malignant brain tumors, GBMs revealing unique immune compositions of GBM subtypes. Congratulations to Longsha Liu who led the work and co-authors at CSTI. These findings open new avenues for treating GBMs. frontiersin.org/articles/10.33…